GPX4 and hepatocellular carcinoma: Network pharmacological and bioinformatic analyses predicted that ECH induces ferroptosis in HCC by modulating the TP53/SLC7A11/GPX4 pathway (upregulating TP53 and downregulating SLC7A11/GPX4).